Open AccessErythrocyte hemighosts in a patient with tumor lysis syndrome: One train may hide another
Author(s) -
Cabantous Pierre,
Daliphard Sylvie,
Bobée Victor
Publication year - 2020
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3011
Subject(s) - tumor lysis syndrome , rasburicase , medicine , hyperuricemia , hematology , anemia , hemolysis , lysis , intensive care medicine , pathology , immunology , uric acid , chemotherapy
Rasburicase was introduced to treat hyperuricemia secondary to tumor lysis syndrome. Because of severe hemolytic anemia, a blood smear was requested and showed hemighosts, revealing G6PD deficiency. Erythrocyte morphology is a key tool in laboratory hematology.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom